Moderna: Coronavirus vaccine nearly 95% effective in early look

Moderna’s coronavirus vaccine was nearly 95% effective and thwarted severe disease in an interim analysis, the company said Monday, putting a second drugmaker on track to request emergency approval before the end of the year.

The Cambridge, Massachusetts, company said it counted 95 cases within its trial of 30,000 participants. Only five of them were in the vaccine arm of the trial, versus 90 in the placebo group.

It also looked at 11 severe cases of COVID-19 and found that all of those participants received the dummy shots, not the...